What's new with us

Stay updated by reading our latest news

We work hard with cancer clinics, research institutes and life sciences partners to provide each cancer patient with more personalised care. Read more below.

Latest Updates

New scientific evidence: Kaiku Health Digital Patient Monitoring enhances the early detection of evolving peripheral sensory neuropathy and reduces phone call burden

Oulu University Hospital, Vaasa Central Hospital and Elekta (Kaiku Health) have published the first scientific results from a study investigating the use of digital patient monitoring for colorectal cancer (CRC) patients receiving oxaliplatin-based chemotherapy. The study was designed to investigate whether digital patient monitoring could enhance and personalize symptom management as well as improve patient...

Read the article

Results presented at ESMO 2022: Kaiku Health digital patient monitoring platform can help in resolving acute fever in melanoma patients

A multicenter study led by the Netherlands Cancer Institute used Kaiku Health digital patient management platform to investigate the use of digital patient monitoring and support of patients with advanced melanoma. The results published at ESMO 2022 annual conference suggest that Kaiku Health can be used to support patients and to collect real-world evidence. They...

Read the article

Kaiku Health expands partnership with a leading global medicines company to provide improved cancer care to more patients across multiple indications

Last year Kaiku Health, a leading digital therapeutics platform for cancer care, announced its collaboration with Novartis, a leading global medicines company, in developing digital patient monitoring and management for melanoma patients. Following the success of the collaboration, Kaiku Health and Novartis are now expanding it into a partnership. “Our goal is to make precision...

Read the article

Results presented at ASCO 2022: patient-reported symptom data can predict antibody levels against SARS-COV-2 on vaccinated cancer patients

Research conducted at the University Hospital Geneva aimed to investigate the potential correlation between symptom burden reported through electronic patient-reported outcomes (ePRO) and the serological response to SARS-CoV-2 vaccines on cancer patients. The promising results are presented at ASCO 2022 this week. The results show that a machine learning model based on patient-reported symptom data...

Read the article

Follow us on social platforms

Media contact

Ellen Nurmi
+358 445512744


Get in touch with us

Interested in learning more about Kaiku Health? Send us a note